VYST (Vystar) Debt-to-Asset : 1.57 (As of Sep. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Vystar Debt-to-Asset?

Vystar's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.93 Mil. Vystar's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.00 Mil. Vystar's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was $0.59 Mil. Vystar's debt to asset for the quarter that ended in Sep. 2024 was 1.57.

Vystar Debt-to-Asset Historical Data

The historical data trend for Vystar's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vystar Debt-to-Asset Chart

Vystar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.67

0.64

0.34

0.04

0.75

Vystar Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.08	0.75	0.84	1.29	1.57

Competitive Comparison of Vystar's Debt-to-Asset

For the Specialty Chemicals subindustry, Vystar's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vystar's Debt-to-Asset Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vystar's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Vystar's Debt-to-Asset falls into.

Vystar Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Vystar's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.533	+	0)	/	0.712
	=	0.75

Vystar's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.925	+	0)	/	0.589
	=	1.57

Vystar (OTCPK:VYST) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Vystar Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Vystar's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Vystar Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vystar Corp (OTCPK:VYST) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

365 Shrewsbury Street, Worcester, MA, USA, 01604

Website

https://www.vytex.com

Vystar Corp is engaged in the rubber and plastic products market. It develops technology to produce Vytex Natural Rubber Latex which reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The company's products and services include Natural Rubber Latex, and clinical sleep diagnostics and durable medical equipment. The company derives revenue from sales of or license fees of Vytex NRL raw material to manufacturers and distributors of rubber and rubber end products.

Executives

Byron Lee Novosad	other: Board Member	14019 SW FREEWAY, # 301 PMB 181, SUGAR LAND TX 77478
Bryan Lawrence Stone	director	C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Keith D. Osborn	10 percent owner	5671 PEACHTREE-DUNWOODY RD., ATLANTA GA 30342
Paul R. Oristaglio	director	955 COUNTY ROAD, BARRINGTON RI 02806
Steven Rotman	director, officer: Chief Executive Officer	C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
Joseph Carmen Allegra	director	C/O VYSTAR CORPORATION, 101 AYLESBURY RD., WORCESTER MA 01609
William R. Doyle	director, officer: Chairman, President & CEO	VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Joseph Allegra	director	VYSTAR CORPORATION, 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Jason M. Meggs	director	C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Ranjit K. Matthan	director	C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Mangum Michelle (mitsy) Y.	director	VYSTAR CORPORATION, 3235 SATELLITE BLVD, BUILDING 400, SUITE 290, DULUTH GA 30096
Michael X Ianacone	director	C/O VYSTAR CORPORATION, 2484 BRIARCLIFF RD NE, SUITE 159, ATLANTA GA 30329
Thomas L Mills	director	C/O WINSTON & STRAWN,, 1400 L. STREET, N.W, WASHINGTON DC 20005
Paul A. Yeoham	director	C/O VYSTAR CORP., 3235 SATELLITE BLVD., BUILDING 400, SUITE 290, DULUTH GA 30096
Dale Thomas Marsh	director	C/O VYSTAR CORPORATION, 3235 SATELLITE BLVD., BLDG. 400, STE 290, DULUTH GA 30096